TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Selenium status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Best spectacle-corrected distance visual acuity (CDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic right ventricle fractional area change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systemic right ventricle global longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Degree of blood pressure decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion Vaccinated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sequential Request Strategy Effectiveness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Testing and Vaccination Offer Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of enrolled participants who complete the study intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient satisfaction for MIST app: Client Satisfaction Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postpartum uterine pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of SARS CoV-2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects who have PCR confirmed SARS-CoV-2 infection
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of subjects with treatment-emergent adverse events (TEAEs) and severity of TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects who subsequently develop moderate to severe COVID-19 infection
Endpoint domain: Mortality/survival
Primary endpoint: Gut dysbiosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postprandial Bile Acid Response to High-Fat Meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial Triglyceride Response to High-Fat Meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial Serum Inflammatory Cytokine Response to High-fat Meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevention of wound biofilm infection
Endpoint domain: Adverse events/effects
Primary endpoint: Psychological Distress - Anxiety and Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Suppression rate of premature LH surge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with ctDNA in CSF or plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood oxygen-level dependent (BOLD) signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting-state functional connectivity in brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: improvement in Clinical Healing score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving a decrease in mean diurnal IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean Change in DIOP from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Postural Assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change from Baseline in Acne Scar Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with serum uric acid level < 360μmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in DAS-28 CRP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Multi Dimensional Health Assessment score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Visual analog scale for pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change of Patient Related Wrist Evaluation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in EEG reading frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in EEG reading waveforms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in EEG reading amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in EEG reading patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentages of Participants With a 4-fold Rise in hSBA Titers Against N. Meningitidis Serogroups A, C, W, and Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Any Unsolicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: postoperative sexual function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: retinal nerve fibre layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of cases
Endpoint domain: Mortality/survival
Primary endpoint: Fractional anisotropy (FA) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Regression of Cervical Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Transfusion Reduction Response (TRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in O2 consumption (VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in CO2 production (VCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in Minute Ventilation (VE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in vocabulary knowledge as assessed by the LARRC Target Word Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in a child's ability to comprehend short passages they read, as assessed by the LARRC Reading Comprehension Measure
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in reading comprehension, as assessed by the norm-referenced Gates-McGinitie Reading Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) of BG-68501
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complete renal response (CRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean fasting blood sugar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Circulating Tumor Deoxyribonucleic Acid (ctDNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Engagement (Percentage of Daily check-in Activities)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: COVID-19 Prevention Health Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COVID-19 Knowledge and Attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes Towards COVID-19 Vaccines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: stage 3 acute renal failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: severe acute respiratory distress syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean score in Online survey for clinicians
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean score in Online survey for informal caregivers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: System functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analytical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V/Q mismatch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Presence of anti-Spike neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: number of Fetomaternal platelet incompatibilities detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with adverse events/serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Hill-Bone Hypertension Treatment Adherence Scale (HBHTUS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Care Management Scale in Chronic Diseases (KHÖBYÖ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Scale of Adjustment to Chronic Diseases (CHU)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The 6-item Self-Efficacy for Managing Chronic Diseases Scale(SEMCD6)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Treatment Decision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete pain response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically Significant Event (CSE) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of structural damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of physical disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visual Analogue Scale Pain Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eosinophilic vs non-eosinophilic remaining exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Successful Medicaid coverage renewal
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Mean Sleep Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Systolic Blood Pressure Dip Pre- vs Post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall clinical treatment efficacy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance of staphylococci to mupirocin and linezolid antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in functional treatment outcome in patients with prostate cancer
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of bioprosthetic valve deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CVC-related thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in MMN-RODS centile score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of rescue analgesic consumption (tramadol)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain intensity using Numerical Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional shift in mRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Biomarkers Associated with Preprogrammed Cell Death (PNCDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of Synaptic Integrity Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of TNF-α (Inflammatory Biomarker)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of interleukins, IL-1β, IL-6, and IL-10 (Inflammatory Biomarker)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of Exosome-Derived Alzheimer's Disease-Specific Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Occurrence of AEs/SAEs in the affected lower extremity/extremities
Endpoint domain: Adverse events/effects
Primary endpoint: Patient's outcome
Endpoint domain: Mortality/survival
Primary endpoint: Adverse Event (including serious adverse event)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with abnormal clinically significant results from physical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with abnormal clinically significant 12-lead electrocardiogram (ECG) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects with abnormal clinically significant clinical laboratory results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycated haemoglobin HbA1c (∆HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and tolerability of LNCB74
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 dose (RP2D) of LNCB74
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: prevalence of renal dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Gender Congruence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Electronic Fetal Monitoring Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success Test for Electronic Fetal Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Skill Form for Electronic Fetal Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Differences in blood microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Participant's discomfort after intravitreal injection
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Residual Lumen Volume Stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Patients who are MRD-negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with delayed engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe infection related complications (≥ Grade 4 NCI CTCAE v5)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Grade 2 or higher diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in mean Prognostic Nutritional Index at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in mean neutrophil-lymphocyte ratio at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in mean platelet-lymphocyte ratio at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Probability of overnight hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in olfactory score on the University of Pennsylvania Identification Test (UPSIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in olfactory score on the Sniffin's Sticks test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in olfactory score on the in-house test for chemosensory dysfunction (TMSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenation Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response outcome adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in post-acne atrophic scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants with very Hazardous Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Undetectable HIV Viral Loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time zero to the last non-zero concentration after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants in each help-seeking category
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Threshold score for identifying Clinical High-Risk Youth online
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: management of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: management of cognitive difficulty
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of self-reported falls per participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Extremity Functional Index Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients suffered from Acute Kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of patients suffered from Perioperative myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients suffered from perioperative organ injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of immediate bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Trail Making Test
Endpoint domain: Cognitive functioning
Primary endpoint: Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Symptoms Resolution of Erosive Esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Binocular single vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional capacities on 30 Seconds Chair Stand Test (30CST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Negative Histological Findings for Prostate Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: pulmonary ribcage asymmetry score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any complications
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients achieving clinical response (ACR20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (AEs) or serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ballooning
Endpoint domain: Adverse events/effects
Primary endpoint: PCR-corrected adequate clinical and parasitological response (ACPR) at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in patients pain scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: change in patients anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stent expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in SPO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 2-Minutes Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of drive time with accelerator pedal pushed down further than 9 degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overestimation of the body schema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean bone density at the fracture line
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Grade of synovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor deposit in the posterior gastric mesentery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mc Gill Pain Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Women's Health Initiative Insomnia Rating Scale (WHIIRS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Correlation between microbiome biomarkers and FIT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural Complications following placement
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Outcomes at Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes